Editorial Expression of Concern: Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cellsNATURE MEDICINEIF502024-11-200OA
Epidermal growth factor induction of the c-jun promoter by a Rac pathwayMOLECULAR AND CELLULAR BIOLOGYIF2.72023-03-28105OAAI
GSK3β-SCFFBXW7α mediated phosphorylation and ubiquitination of IRF1 are required for its transcription-dependent turnoverNUCLEIC ACIDS RESEARCHIF13.12019-03-1125OAAI
Bladder control increases the incidence of urinary retention after epidural analgesia after paediatric orthopaedic surgeryBRITISH JOURNAL OF ANAESTHESIAIF9.22012-08-012OAAI
A ChIPchip approach reveals a novel role for transcription factor IRF1 in the DNA damage responseNUCLEIC ACIDS RESEARCHIF13.12009-01-0756OAAI
Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosisCELL DEATH AND DIFFERENTIATIONIF15.42007-09-0735OAAI
Acute myeloid leukemia: Therapeutic impact of epigenetic drugs急性髓系白血病: 表观遗传药物的治疗影响INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGYIF2.82005-09-0149PRE
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells (Publication with Expression of Concern. See NOV, 2024)NATURE MEDICINEIF502004-12-26503PREAI
Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAILEMBO JOURNALIF8.32004-07-08137OAAI